Corona’s Indigenous Medicine 2-dg Will Soon Be Available In The Market! This Company Got License From Drdo – Covid 19 News-The Defense Research and Development Organization (DRDO) has licensed the manufacturing and marketing of Corona’s drug 2-DG (2-deoxy-D-glucose) to the drug company Mankind Pharma. In such a situation, it can be expected that very soon this medicine will be available in the neighboring drug shops.
Corona’s Indigenous Medicine 2-dg Will Soon Be Available In The Market! This Company Got License From Drdo – Covid 19 News
medicine developed in gwalior
The 2-DG drug has been developed by the Gwalior-based Defense Research and Development Establishment (DRDE). PTI has reported on the basis of the statement of Mankind Pharma that its clinical trial has been done by a lab of DRDO by Institute of Nuclear Medicine and Allied Sciences (INMAS). INMAS carried out this in collaboration with Dr Reddy’s Laboratories.
Medicine will be made in Himachal and Visakhapatnam
Mankind says that the 2-DG will be manufactured at its factories in Himachal Pradesh and Visakhapatnam. Indian drug regulator DCGI has already allowed the use of 2-DG in the treatment of common and severe patients of corona on 1 May. This medicine is taken by mouth.
Lockdown News – Corona Case Stops In Up, Curfew Or Relaxation Will Increase, Decision Of State Government Today
Effective medicine on hospitalized patients
The effect of this drug was found to be positive on the patients admitted to the hospital due to corona. This helped him make a quick recovery. Not only this, due to this medicine his dependence on oxygen also decreased.
Objective to deliver medicine to more and more Indians
Mankind Pharma says that the objective of the company is to ensure the access of this medicine to maximum people. So that the needy Indian patients battling this terrible epidemic can get the benefit.
